Professional risks when carrying out cytoreductive surgery for peritoneal malignancy with hyperthermic intraperitoneal chemotherapy (HIPEC): A French multicentric survey

Professional risks when carrying out cytoreductive surgery for peritoneal malignancy with hyperthermic intraperitoneal chemotherapy (HIPEC): A French multicentric survey. Ferron, G., Simon, L., Guyon, F., Glehen, O., Goere, D., Elias, D., Pocard, M., Gladieff, L., Bereder, J. M., Brigand, C., Classe, J. M., Guilloit, J. M., Quenet, F., Abboud, K., Arvieux, C., Bibeau, F., De Chaisemartin, C., Delroeux, D., Durand-Fontanier, S., Goasguen, N., Gouthi, L., Heyd, B., Kianmanesh, R., Leblanc, E., Loi, V., Lorimier, G., Marchal, F., Mariani, P., Mariette, C., Meeus, P., Msika, S., Ortega-Deballon, P., Paineau, J., Pezet, D., Piessen, G., Pirro, N., Pomel, C., Porcheron, J., Pourcher, G., Rat, P., Regimbeau, J. M., Sabbagh, C., Thibaudeau, E., Torrent, J. J., Tougeron, D., Tuech, J. J., Zinzindohoue, F., Lundberg, P., Herin, F., Villeneuve, L., & Group, B. W. Eur J Surg Oncol, 41(10):1361–7, October, 2015.

Paper doi abstract bibtex

BACKGROUND: Over the last two decades, many surgical teams have developed programs to treat peritoneal carcinomatosis with extensive cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Currently, there are no specific recommendations for HIPEC procedures concerning environmental contamination risk management, personal protective equipment (PPE), or occupational health supervision. METHODS: A survey of the institutional practices among all French teams currently performing HIPEC procedures was carried out via the French network for the treatment of rare peritoneal malignancies (RENAPE). RESULTS: Thirty three surgical teams responded, 14 (42.4%) which reported more than 10 years of HIPEC experience. Some practices were widespread, such as using HIPEC machine approved by the European Community (100%), individualized or centralized smoke evacuation (81.8%), "open" abdominal coverage during perfusion (75.8%), and maintaining the same surgeon throughout the procedure (69.7%). Others were more heterogeneous, including laminar flow air circulation (54.5%) and the provision of safety protocols in the event of perfusate spills (51.5%). The use of specialized personal protective equipment is ubiquitous (93.9%) but widely variable between programs. CONCLUSION: Protocols regarding cytoreductive surgery/HIPEC and the associated professional risks in France lack standardization and should be established.

@article{ferron_professional_2015,
	title = {Professional risks when carrying out cytoreductive surgery for peritoneal malignancy with hyperthermic intraperitoneal chemotherapy ({HIPEC}): {A} {French} multicentric survey},
	volume = {41},
	issn = {1532-2157 (Electronic) 0748-7983 (Linking)},
	url = {http://www.ncbi.nlm.nih.gov/pubmed/26263848},
	doi = {10.1016/j.ejso.2015.07.012},
	abstract = {BACKGROUND: Over the last two decades, many surgical teams have developed programs to treat peritoneal carcinomatosis with extensive cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Currently, there are no specific recommendations for HIPEC procedures concerning environmental contamination risk management, personal protective equipment (PPE), or occupational health supervision. METHODS: A survey of the institutional practices among all French teams currently performing HIPEC procedures was carried out via the French network for the treatment of rare peritoneal malignancies (RENAPE). RESULTS: Thirty three surgical teams responded, 14 (42.4\%) which reported more than 10 years of HIPEC experience. Some practices were widespread, such as using HIPEC machine approved by the European Community (100\%), individualized or centralized smoke evacuation (81.8\%), "open" abdominal coverage during perfusion (75.8\%), and maintaining the same surgeon throughout the procedure (69.7\%). Others were more heterogeneous, including laminar flow air circulation (54.5\%) and the provision of safety protocols in the event of perfusate spills (51.5\%). The use of specialized personal protective equipment is ubiquitous (93.9\%) but widely variable between programs. CONCLUSION: Protocols regarding cytoreductive surgery/HIPEC and the associated professional risks in France lack standardization and should be established.},
	number = {10},
	journal = {Eur J Surg Oncol},
	author = {Ferron, G. and Simon, L. and Guyon, F. and Glehen, O. and Goere, D. and Elias, D. and Pocard, M. and Gladieff, L. and Bereder, J. M. and Brigand, C. and Classe, J. M. and Guilloit, J. M. and Quenet, F. and Abboud, K. and Arvieux, C. and Bibeau, F. and De Chaisemartin, C. and Delroeux, D. and Durand-Fontanier, S. and Goasguen, N. and Gouthi, L. and Heyd, B. and Kianmanesh, R. and Leblanc, E. and Loi, V. and Lorimier, G. and Marchal, F. and Mariani, P. and Mariette, C. and Meeus, P. and Msika, S. and Ortega-Deballon, P. and Paineau, J. and Pezet, D. and Piessen, G. and Pirro, N. and Pomel, C. and Porcheron, J. and Pourcher, G. and Rat, P. and Regimbeau, J. M. and Sabbagh, C. and Thibaudeau, E. and Torrent, J. J. and Tougeron, D. and Tuech, J. J. and Zinzindohoue, F. and Lundberg, P. and Herin, F. and Villeneuve, L. and Group, Big-Renape Working},
	month = oct,
	year = {2015},
	keywords = {*Practice Patterns, Air Conditioning/*methods, Antineoplastic Agents/*therapeutic use, Carcinoma/*therapy, Cytoreduction Surgical Procedures/*methods, France, Humans, Hyperthermia, Induced/*methods, Infusions, Occupational Health, Parenteral/*methods, Peritoneal Neoplasms/*therapy, Personal Protective Equipment/*utilization, Physicians', Risk Management, Smoke, Surveys and Questionnaires},
	pages = {1361--7},
}

Downloads: 0